{"id":"https://openalex.org/W1500533946","doi":null,"title":"MR metabolic characterization of locally advanced breast cancer : \u2013 treatment effects and prognosis","display_name":"MR metabolic characterization of locally advanced breast cancer : \u2013 treatment effects and prognosis","alternate_titles":[],"publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W1500533946","mag":"1500533946"},"language":"en","primary_location":{"id":"pmh:oai:ntnuopen.ntnu.no:11250/264783","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/11250/264783","pdf_url":null,"source":{"id":"https://openalex.org/S7407064446","display_name":"NORA - Norwegian Open Research Archives","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/doctoralThesis"},"parent_works":[],"lineage":["https://openalex.org/W1500533946"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/11250/264783","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103876120","display_name":"Maria Dung Cao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Maria Dung Cao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5103876120"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11885","display_name":"MRI in cancer diagnosis","score":0.7188000082969666,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11885","display_name":"MRI in cancer diagnosis","score":0.7188000082969666,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.14419999718666077,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10836","display_name":"Metabolomics and Mass Spectrometry Studies","score":0.042899999767541885,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/locally-advanced-breast-cancer","display_name":"locally advanced breast cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/mr-spectroscopy","display_name":"MR spectroscopy","score":0.6639999747276306},{"id":"https://openalex.org/keywords/metabolomics","display_name":"metabolomics","score":0.6830000281333923},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.8690000176429749},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.9710000157356262},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.7960000038146973},{"id":"https://openalex.org/keywords/survival-prediction","display_name":"survival prediction","score":0.6600000262260437},{"id":"https://openalex.org/keywords/choline-containing-compounds","display_name":"choline-containing compounds","score":0.6880000233650208},{"id":"https://openalex.org/keywords/lactate","display_name":"lactate","score":0.7820000052452087},{"id":"https://openalex.org/keywords/glycerophosphodiester-phosphodiesterase","display_name":"glycerophosphodiester phosphodiesterase","score":0.8640000224113464},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6380000114440918},{"id":"https://openalex.org/keywords/personalized-treatment","display_name":"personalized treatment","score":0.42100000381469727},{"id":"https://openalex.org/keywords/treatment-response-monitoring","display_name":"treatment response monitoring","score":0.33799999952316284},{"id":"https://openalex.org/keywords/lymph-node-metastasis","display_name":"lymph node metastasis","score":0.5789999961853027},{"id":"https://openalex.org/keywords/hormone-receptor-status","display_name":"hormone receptor status","score":0.8730000257492065},{"id":"https://openalex.org/keywords/tumor-grade","display_name":"tumor grade","score":0.6349999904632568}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6887549161911011},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5196743607521057},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4641261100769043},{"id":"https://openalex.org/C2780841128","wikidata":"https://www.wikidata.org/wiki/Q5073781","display_name":"Characterization (materials science)","level":2,"score":0.4183383285999298},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4181448221206665},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36521631479263306},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.35172563791275024},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.14126139879226685},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.10398072004318237}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:ntnuopen.ntnu.no:11250/264783","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/11250/264783","pdf_url":null,"source":{"id":"https://openalex.org/S7407064446","display_name":"NORA - Norwegian Open Research Archives","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/doctoralThesis"},{"id":"mag:1500533946","doi":null,"is_oa":false,"landing_page_url":"https://brage.bibsys.no/xmlui/handle/11250/264783","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:ntnuopen.ntnu.no:11250/264783","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/11250/264783","pdf_url":null,"source":{"id":"https://openalex.org/S7407064446","display_name":"NORA - Norwegian Open Research Archives","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/doctoralThesis"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1486422396","https://openalex.org/W1522505461","https://openalex.org/W1550989298","https://openalex.org/W1605046409","https://openalex.org/W1970312353","https://openalex.org/W2007352226","https://openalex.org/W2007416032","https://openalex.org/W2008004993","https://openalex.org/W2009765233","https://openalex.org/W2046687522","https://openalex.org/W2050059533","https://openalex.org/W2064367468","https://openalex.org/W2073503722","https://openalex.org/W2085177488","https://openalex.org/W2086257496","https://openalex.org/W2087134458","https://openalex.org/W2087481249","https://openalex.org/W2091006673","https://openalex.org/W2092155681","https://openalex.org/W2093767384","https://openalex.org/W2097259163","https://openalex.org/W2097716112","https://openalex.org/W2098722265","https://openalex.org/W2102348134","https://openalex.org/W2103994616","https://openalex.org/W2106926141","https://openalex.org/W2108560895","https://openalex.org/W2116309666","https://openalex.org/W2122133674","https://openalex.org/W2122380937","https://openalex.org/W2130648981","https://openalex.org/W2139782977","https://openalex.org/W2139996308","https://openalex.org/W2142765712","https://openalex.org/W2148420701","https://openalex.org/W2149727021","https://openalex.org/W2150406132","https://openalex.org/W2153556784","https://openalex.org/W2163471981","https://openalex.org/W2169664675","https://openalex.org/W2171108478"],"related_works":["https://openalex.org/W346716050","https://openalex.org/W7001988615","https://openalex.org/W2248833061","https://openalex.org/W2587908717","https://openalex.org/W249619789","https://openalex.org/W4286292952","https://openalex.org/W2116465095","https://openalex.org/W2039343804","https://openalex.org/W1522505461","https://openalex.org/W2024927974"],"abstract_inverted_index":{"Brystkreft":[0],"er":[1,45,55,71,87,105,123,126,152,156,166,254,292,306],"den":[2,132],"hyppigste":[3],"kreftsykdommen":[4],"blant":[5],"kvinner.":[6],"Lokalavansert":[7],"brystkreft":[8,26,184],"utgj\u00f8r":[9],"omtrent":[10],"10%":[11],"av":[12,33,69,75,114,188,193,208,214,273,286,296,337],"alle":[13,221],"brystkrefttilfeller":[14],"og":[15,53,62,99,162,195,219,264,276,309,330],"omfatter":[16],"en":[17,72,106,111,167,212,223],"heterogen":[18],"pasientgruppe":[19],"med":[20,24,91,120,138,182,236,282,341],"ulike":[21],"prognoser.":[22],"Pasienter":[23],"lokalavansert":[25,183,342],"f\u00e5r":[27],"ofte":[28],"kjemoterapi":[29,253,328],"f\u00f8r":[30,268],"kirurgisk":[31],"fjerning":[32],"tumor,":[34],"s\u00e5kalt":[35],"neoadjuvant":[36,252,327],"kjemoterapi,":[37],"for":[38,50,58,67,95,141,158,191,301,314,335],"\u00e5":[39,59,89,315,322],"redusere":[40],"st\u00f8rrelsen":[41],"p\u00e5":[42,289],"tumoren.":[43],"Det":[44],"stor":[46],"variasjon":[47],"i":[48,79,116,173,206,225,256,294,303],"behandlingsrespons":[49,194],"denne":[51,121],"pasientgruppen,":[52],"det":[54],"derfor":[56],"behov":[57],"utvikle":[60],"m\u00e5lrettet":[61,304],"individualisert":[63],"behandling,":[64],"samt":[65],"metoder":[66],"oppf\u00f8lging":[68],"behandlingsrespons.\\n\\nMetabolomics":[70],"systematisk":[73],"analyse":[74],"sm\u00e5molekyl\u00e6re":[76],"forbindelser":[77],"(metabolitter)":[78],"biologiske":[80],"pr\u00f8ver.":[81],"Den":[82],"metabolske":[83,232,247,324],"profilen":[84],"til":[85,202,313,321],"brystkreftvev":[86],"vist":[88],"korrelere":[90],"viktige":[92,333],"kliniske":[93],"parametere,":[94],"eksempel":[96,142],"tumorgrad,":[97],"hormonreseptorstatus":[98],"lymfeknutespredning.":[100],"Magnetisk":[101],"resonans":[102],"(MR)":[103],"spektroskopi":[104,190],"metode":[107],"som":[108,171,216,249,258,266],"kan":[109,135,319,331],"gi":[110],"detaljert":[112],"beskrivelse":[113],"metabolittprofilen":[115],"vevet.":[117],"En":[118],"fordel":[119],"metoden":[122],"at":[124,131,245,290],"vevspr\u00f8ven":[125,134],"intakt":[127],"etter":[128,227,278],"analysen":[129],"slik":[130],"samme":[133],"analyseres":[136],"videre":[137],"andre":[139],"metoder,":[140],"immunohistokjemi,":[143],"genuttrykk-":[144],"eller":[145,239],"proteinanalyse.\\n\\nEn":[146],"sentral":[147],"gruppe":[148],"metabolitter":[149,334],"innenfor":[150],"brystkreftforskning":[151],"kolinforbindelser.":[153],"Disse":[154],"metabolittene":[155],"viktig":[157,169],"celledeling,":[159],"signaloverf\u00f8ring,":[160],"lipidmetabolisme":[161],"cellens":[163],"membranstruktur.":[164],"Laktat":[165],"annen":[168],"metabolitt":[170],"inng\u00e5r":[172],"energimetabolismen.":[174],"I":[175,197],"dette":[176],"arbeidet":[177],"ble":[178,217],"vevspr\u00f8ver":[179],"fra":[180],"pasienter":[181,210,235,257,340],"analysert":[185],"ved":[186],"bruk":[187,302],"MR":[189],"prediksjon":[192,336],"overlevelse.":[196],"tillegg":[198],"unders\u00f8kte":[199],"vi":[200],"rollen":[201],"glycerophosphodiester":[203],"phosphodiesterase":[204],"(GDPD)":[205],"regulering":[207],"kolinforbindelser\\n\\nAlle":[209],"hadde":[211],"effekt":[213],"behandlingen":[215],"gitt,":[218],"nesten":[220],"fikk":[222],"reduksjon":[224],"tumorst\u00f8rrelse":[226],"behandling.":[228],"Resultatene":[229,242],"viste":[230],"ingen":[231],"forskjeller":[233],"mellom":[234],"klinisk":[237],"god":[238],"d\u00e5rlig":[240,283],"behandlingsrespons.":[241],"viser":[243],"derimot":[244],"de":[246,265],"forandringene":[248],"skjer":[250],"under":[251,326],"forskjellig":[255],"overlever":[259],"mer":[260],"enn":[261],"fem":[262,269],"\u00e5r":[263],"d\u00f8r":[267],"\u00e5r.":[270],"H\u00f8yere":[271],"niv\u00e5":[272],"laktat,":[274],"glycine":[275],"kolinforbindelser":[277],"behandling":[279,329],"var":[280],"forbundet":[281],"prognose.":[284],"Analysene":[285],"GDPD5":[287],"tyder":[288],"enzymet":[291],"involvert":[293],"reguleringen":[295],"kolinmetabolismen,":[297],"men":[298],"dets":[299],"rolle":[300],"terapi":[305],"fortsatt":[307],"uklart":[308],"nye":[310],"studier":[311],"m\u00e5":[312],"unders\u00f8ke":[316,323],"dette.\\n\\nMR":[317],"metabolomics":[318],"brukes":[320],"forandringer":[325],"identifisere":[332],"overlevelse":[338],"hos":[339],"brystkreft.":[343]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1500533946","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
